This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
MESOTHELIOMA
PROMISE-Meso
Multicentre randomised phase III trial comparing pembrolizumab versus standard chemotherapy for advanced pre-treated malignant pleural mesothelioma.
Promotor: ETOP
Coordinador en España: Dr. Ernest Nadal
Centros participantes
- Institut Català d’Oncologia-Hospitalet
- Hospital Clínico Universitario de Valladolid
- Hospital Teresa Herrera, A Coruña